Practice variations for fetal and neonatal congenital heart disease within the Children's Hospitals Neonatal Consortium.


Journal

Pediatric research
ISSN: 1530-0447
Titre abrégé: Pediatr Res
Pays: United States
ID NLM: 0100714

Informations de publication

Date de publication:
05 2023
Historique:
received: 04 05 2022
accepted: 03 09 2022
revised: 09 08 2022
medline: 12 5 2023
pubmed: 28 9 2022
entrez: 27 9 2022
Statut: ppublish

Résumé

Many aspects of care for fetuses and neonates with congenital heart disease (CHD) fall outside standard practice guidelines, leading to the potential for significant variation in clinical care for this vulnerable population. We conducted a cross-sectional survey of site sponsors of the Children's Hospitals Neonatal Consortium, a multicenter collaborative of 41 Level IV neonatal intensive care units to assess key areas of clinical practice variability for patients with fetal and neonatal CHD. We received responses from 31 centers. Fetal consult services are shared by neonatology and pediatric cardiology at 70% of centers. Three centers (10%) routinely perform fetal magnetic resonance imaging (MRI) for women with pregnancies complicated by fetal CHD. Genetic testing for CHD patients is routine at 76% of centers. Preoperative brain MRI is standard practice at 5 centers (17%), while cerebral NIRS monitoring is regularly used at 14 centers (48%). Use of electroencephalogram (EEG) after major cardiac surgery is routine in 5 centers (17%). Neurodevelopmental follow-up programs are offered at 30 centers (97%). Many aspects of fetal and neonatal CHD care are highly variable with evolving shared multidisciplinary models. Many aspects of fetal and neonatal CHD care are highly variable. Genetic testing, placental examination, preoperative neuroimaging, and postoperative EEG monitoring carry a high yield of finding abnormalities in patients with CHD and these tests may contribute to more precise prognostication and improve care. Evidence-based standards for prenatal and postnatal CHD care may decrease inter-center variability.

Sections du résumé

BACKGROUND
Many aspects of care for fetuses and neonates with congenital heart disease (CHD) fall outside standard practice guidelines, leading to the potential for significant variation in clinical care for this vulnerable population.
METHODS
We conducted a cross-sectional survey of site sponsors of the Children's Hospitals Neonatal Consortium, a multicenter collaborative of 41 Level IV neonatal intensive care units to assess key areas of clinical practice variability for patients with fetal and neonatal CHD.
RESULTS
We received responses from 31 centers. Fetal consult services are shared by neonatology and pediatric cardiology at 70% of centers. Three centers (10%) routinely perform fetal magnetic resonance imaging (MRI) for women with pregnancies complicated by fetal CHD. Genetic testing for CHD patients is routine at 76% of centers. Preoperative brain MRI is standard practice at 5 centers (17%), while cerebral NIRS monitoring is regularly used at 14 centers (48%). Use of electroencephalogram (EEG) after major cardiac surgery is routine in 5 centers (17%). Neurodevelopmental follow-up programs are offered at 30 centers (97%).
CONCLUSIONS
Many aspects of fetal and neonatal CHD care are highly variable with evolving shared multidisciplinary models.
IMPACT
Many aspects of fetal and neonatal CHD care are highly variable. Genetic testing, placental examination, preoperative neuroimaging, and postoperative EEG monitoring carry a high yield of finding abnormalities in patients with CHD and these tests may contribute to more precise prognostication and improve care. Evidence-based standards for prenatal and postnatal CHD care may decrease inter-center variability.

Identifiants

pubmed: 36167818
doi: 10.1038/s41390-022-02314-2
pii: 10.1038/s41390-022-02314-2
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1728-1735

Investigateurs

Kevin Sullivan (K)
Victor McKay (V)
Jamie Limjoco (J)
Karna Murthy (K)
Gustave Falciglia (G)
Robert Lyle (R)
Becky Rogers (B)
Cherie Welch (C)
Anthony Piazza (A)
Priscilla Joe (P)
Anne Hansen (A)
Theresa Grover (T)
Carl Coghill (C)
Toby Yanowitz (T)
Rashmin Savani (R)
Eugenia Pallotto (E)
Billie Short (B)
An Massaro (A)
Gregory Sysyn (G)
Rachel Chapman (R)
Girija Natarajan (G)
Lynne Willett (L)
Nicole Birge (N)
Michael Uhing (M)
Ankur Datta (A)
Michel Mikhael (M)
Beth Haberman (B)
Annmarie Golioto (A)
Annie Chi (A)
Yvette Johnson (Y)
Rajan Wadhawan (R)
Kyong-Soon Lee (KS)
Ajay Talati (A)
Kristina Reber (K)
Con Yee Ling (CY)
Mark Speziale (M)
Laurel Moyer (L)
William Engle (W)
Elizabeth Jacobsen-Misbe (E)
Robert DiGeronimo (R)
Suzanne Touch (S)
Rakesh Rao (R)
Beverly Brozanski (B)
Gautham Suresh (G)
Michael Padula (M)
David Munson (D)

Informations de copyright

© 2022. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Références

Hoffman, J. I. & Kaplan, S. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 39, 1890–1900 (2002).
doi: 10.1016/S0735-1097(02)01886-7 pubmed: 12084585
van der Linde, D. et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 58, 2241–2247 (2011).
pubmed: 22078432 doi: 10.1016/j.jacc.2011.08.025
International Society of Ultrasound in Obstetrics & Gynecology. Cardiac screening examination of the fetus: guidelines for performing the ‘basic’ and ‘extended basic’ cardiac scan. Ultrasound Obstet. Gynecol. 27, 107–113 (2006).
doi: 10.1002/uog.2677
Lee, W. et al. ISUOG consensus statement: what constitutes a fetal echocardiogram? Ultrasound Obstet. Gynecol. 32, 239–242 (2008).
pubmed: 18663769 doi: 10.1002/uog.6115
Sklansky, M. et al. Maternal psychological impact of fetal echocardiography. J. Am. Soc. Echocardiogr. 15, 159–166 (2002).
pubmed: 11836491 doi: 10.1067/mje.2002.116310
Alder, J., Fink, N., Bitzer, J., Hosli, I. & Holzgreve, W. Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J. Matern. Fetal Neonatal Med. 20, 189–209 (2007).
pubmed: 17437220 doi: 10.1080/14767050701209560
Brosig, C. L., Whitstone, B. N., Frommelt, M. A., Frisbee, S. J. & Leuthner, S. R. Psychological distress in parents of children with severe congenital heart disease: the impact of prenatal versus postnatal diagnosis. J. Perinatol. 27, 687–692 (2007).
pubmed: 17717519 doi: 10.1038/sj.jp.7211807
Wu, Y. et al. Association of maternal psychological distress with in utero brain development in fetuses with congenital heart disease. JAMA Pediatr. 174, e195316 (2020).
pubmed: 31930365 pmcid: 6990726 doi: 10.1001/jamapediatrics.2019.5316
Hamrick, S. E. G. et al. Integrated cardiac care models of neonates with congenital heart disease: the evolving role of the neonatologist. J. Perinatol. 41, 1774–1776 (2021).
pubmed: 34140645 doi: 10.1038/s41372-021-01117-3
Langston, C. et al. Practice guideline for examination of the placenta: developed by the Placental Pathology Practice Guideline Development Task Force of the College of American Pathologists. Arch. Pathol. Lab. Med. 121, 449–476 (1997).
pubmed: 9167599
Singh, Y. et al. Recommendations for hemodynamic monitoring for critically ill children-expert consensus statement issued by the Cardiovascular Dynamics Section of the European Society of Paediatric and Neonatal Intensive Care (Espnic). Crit. Care 24, 620 (2020).
pubmed: 33092621 pmcid: 7579971 doi: 10.1186/s13054-020-03326-2
Shellhaas, R. A. et al. The American Clinical Neurophysiology Society’s guideline on continuous electroencephalography monitoring in neonates. J. Clin. Neurophysiol. 28, 611–617 (2011).
pubmed: 22146359 doi: 10.1097/WNP.0b013e31823e96d7
Marino, B. S. et al. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a Scientific Statement from the American Heart Association. Circulation 126, 1143–1172 (2012).
pubmed: 22851541 doi: 10.1161/CIR.0b013e318265ee8a
Harris, P. A. et al. Research Electronic Data capture (REDcap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inf. 42, 377–381 (2009).
doi: 10.1016/j.jbi.2008.08.010
Harris, P. A. et al. The REDcap Consortium: building an international community of software platform partners. J. Biomed. Inf. 95, 103208 (2019).
doi: 10.1016/j.jbi.2019.103208
Miquel-Verges, F. et al. Prenatal consultation with a neonatologist for congenital anomalies: parental perceptions. Pediatrics 124, e573–e579 (2009).
pubmed: 19736266 doi: 10.1542/peds.2008-2865
Leithner, K., Maar, A. & Maritsch, F. Experiences with a psychological help service for women following a prenatal diagnosis: results of a follow-up study. J. Psychosom. Obstet. Gynaecol. 23, 183–192 (2002).
pubmed: 12436804 doi: 10.3109/01674820209074671
Rychik, J. et al. Maternal psychological stress after prenatal diagnosis of congenital heart disease. J. Pediatr. 162, 302.e1–307.e1 (2013).
doi: 10.1016/j.jpeds.2012.07.023
Bratt, E. L. et al. Parental reactions, distress, and sense of coherence after prenatal versus postnatal diagnosis of complex congenital heart disease. Cardiol. Young 29, 1328–1334 (2019).
pubmed: 31522698 doi: 10.1017/S1047951119001781
Maina, G. et al. Impact of maternal psychological distress on fetal weight, prematurity and intrauterine growth retardation. J. Affect. Disord. 111, 214–220 (2008).
pubmed: 18394713 doi: 10.1016/j.jad.2008.02.017
Fenster, L. et al. Psychologic stress in the workplace and spontaneous abortion. Am. J. Epidemiol. 142, 1176–1183 (1995).
pubmed: 7485064 doi: 10.1093/oxfordjournals.aje.a117576
Kurki, T., Hiilesmaa, V., Raitasalo, R., Mattila, H. & Ylikorkala, O. Depression and anxiety in early pregnancy and risk for preeclampsia. Obstet. Gynecol. 95, 487–490 (2000).
pubmed: 10725477
Van den Bergh, B. R., Mulder, E. J., Mennes, M. & Glover, V. Antenatal maternal anxiety and stress and the neurobehavioural development of the fetus and child: links and possible mechanisms. a review. Neurosci. Biobehav. Rev. 29, 237–258 (2005).
pubmed: 15811496 doi: 10.1016/j.neubiorev.2004.10.007
Harris, K. W., Brelsford, K. M., Kavanaugh-McHugh, A. & Clayton, E. W. Uncertainty of prenatally diagnosed congenital heart disease: a qualitative study. JAMA Netw. Open 3, e204082 (2020).
pubmed: 32369178 pmcid: 7201310 doi: 10.1001/jamanetworkopen.2020.4082
Bratt, E. L., Jarvholm, S., Ekman-Joelsson, B. M., Mattson, L. A. & Mellander, M. parent’s experiences of counselling and their need for support following a prenatal diagnosis of congenital heart disease–a qualitative study in a Swedish context. BMC Pregnancy Childbirth 15, 171 (2015).
pubmed: 26276642 pmcid: 4537590 doi: 10.1186/s12884-015-0610-4
Marc-Aurele, K. L. Decisions parents make when faced with potentially life-limiting fetal diagnoses and the importance of perinatal palliative care. Front. Pediatr. 8, 574556 (2020).
pubmed: 33194903 pmcid: 7642456 doi: 10.3389/fped.2020.574556
Afonso, N. S. et al. Redefining the relationship: palliative care in critical perinatal and neonatal cardiac patients. Children 8, 548 (2021).
Committee Opinion No. 723. Guidelines for diagnostic imaging during pregnancy and lactation. Obstet. Gynecol. 130, e210–e216 (2017).
doi: 10.1097/AOG.0000000000002355
Committee on Practice Parameters - Pediatric Radiology of the ACR Commission on Pediatric Radiology. ACR-SPR practice parameter for the safe and optimal performance of fetal magnetic resonance imaging (MRI). https://www.acr.org/-/media/ACR/Files/Practice-Parameters/mr-fetal.pdf (2020).
Herrmann, J. L. et al. Congenital pulmonary lymphangiectasia and early mortality after stage 1 reconstruction procedures. Cardiol. Young 27, 1356–1360 (2017).
pubmed: 28287055 doi: 10.1017/S1047951117000348
Peyvandi, S. et al. Timing and mode of delivery in prenatally diagnosed congenital heart disease- an analysis of practices within the University of California Fetal Consortium (UCFC). Pediatr. Cardiol. 38, 588–595 (2017).
pubmed: 28078382 pmcid: 5969910 doi: 10.1007/s00246-016-1552-y
Castellanos, D. A. et al. Trends in preterm delivery among singleton gestations with critical congenital heart disease. J. Pediatr. 222, 28–34.e4 (2020).
pubmed: 32586534 pmcid: 7377282 doi: 10.1016/j.jpeds.2020.03.003
Kipps, A. K. et al. Prenatal diagnosis of hypoplastic left heart syndrome in current era. Am. J. Cardiol. 108, 421–427 (2011).
pubmed: 21624547 doi: 10.1016/j.amjcard.2011.03.065
Levey, A. et al. The impact of prenatal diagnosis of complex congenital heart disease on neonatal outcomes. Pediatr. Cardiol. 31, 587–597 (2010).
pubmed: 20165844 pmcid: 2889000 doi: 10.1007/s00246-010-9648-2
Ge, C. J. et al. Fetal CHD and perinatal outcomes. Cardiol. Young 30, 686–691 (2020).
pubmed: 32308170 pmcid: 7780156 doi: 10.1017/S1047951120000785
Landis, B. J. et al. Prenatal diagnosis of congenital heart disease and birth outcomes. Pediatr. Cardiol. 34, 597–605 (2013).
pubmed: 23052660 doi: 10.1007/s00246-012-0504-4
Costello, J. M. et al. Gestational age at birth and outcomes after neonatal cardiac surgery: an Analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database. Circulation 129, 2511–2517 (2014).
pubmed: 24795388 pmcid: 4276251 doi: 10.1161/CIRCULATIONAHA.113.005864
Afshar, Y. et al. Multi-institutional practice-patterns in fetal congenital heart disease following implementation of a standardized clinical assessment and management plan. J. Am. Heart Assoc. 10, e021598 (2021).
pubmed: 34315235 pmcid: 8475692 doi: 10.1161/JAHA.121.021598
Roescher, A. M., Timmer, A., Erwich, J. J. & Bos, A. F. Placental pathology, perinatal death, neonatal outcome, and neurological development: a systematic review. PLoS ONE 9, e89419 (2014).
pubmed: 24586764 pmcid: 3934891 doi: 10.1371/journal.pone.0089419
Weiner, E. et al. The role of placental histopathological lesions in predicting recurrence of preeclampsia. Prenat. Diagn. 36, 953–960 (2016).
pubmed: 27568920 doi: 10.1002/pd.4918
Leon, R. L. et al. Neuroplacentology in congenital heart disease: placental connections to neurodevelopmental outcomes. Pediatr. Res. 91, 787–794 (2022).
Mir, I. N. et al. Impact of multiple placental pathologies on neonatal death, bronchopulmonary dysplasia, and neurodevelopmental impairment in preterm infants. Pediatr. Res. 87, 885–891 (2020).
pubmed: 31812153 doi: 10.1038/s41390-019-0715-y
Mir, I. N. et al. Placental pathology is associated with severity of neonatal encephalopathy and adverse developmental outcomes following hypothermia. Am. J. Obstet. Gynecol. 213, 849.e841–847 (2015).
doi: 10.1016/j.ajog.2015.09.072
Benirschke, K. The placenta in the litigation process. Am. J. Obstet. Gynecol. 162, 1445–1448 (1990) ; discussion 1448–1450.
pubmed: 2193514 doi: 10.1016/0002-9378(90)90904-L
Albalawi, A. et al. Placental characteristics of fetuses with congenital heart disease. J. Ultrasound Med. 36, 965–972 (2017).
pubmed: 28258617 doi: 10.7863/ultra.16.04023
Rychik, J. et al. Characterization of the placenta in the newborn with congenital heart disease: distinctions based on type of cardiac malformation. Pediatr. Cardiol. 39, 1165–1171 (2018).
pubmed: 29728721 pmcid: 6096845 doi: 10.1007/s00246-018-1876-x
Pierpont, M. E. et al. Genetic basis for congenital heart disease: revisited: a Scientific Statement from the American Heart Association. Circulation 138, e653–e711 (2018).
pubmed: 30571578 pmcid: 6555769 doi: 10.1161/CIR.0000000000000606
Boskovski, M. T. et al. De novo damaging variants, clinical phenotypes, and post-operative outcomes in congenital heart disease. Circ. Genom. Precis. Med. 13, e002836 (2020).
pubmed: 32812804 pmcid: 7439931 doi: 10.1161/CIRCGEN.119.002836
Landis, B. J. & Ware, S. M. The current landscape of genetic testing in cardiovascular malformations: opportunities and challenges. Front. Cardiovasc. Med. 3, 22 (2016).
pubmed: 27504451 pmcid: 4959014 doi: 10.3389/fcvm.2016.00022
Russell, M. W., Chung, W. K., Kaltman, J. R. & Miller, T. A. Advances in the understanding of the genetic determinants of congenital heart disease and their impact on clinical outcomes. J. Am. Heart Assoc. 7, e006906 (2018).
Miller, S. P. et al. Abnormal brain development in newborns with congenital heart disease. N. Engl. J. Med. 357, 1928–1938 (2007).
pubmed: 17989385 doi: 10.1056/NEJMoa067393
Kelly, C. J. et al. Neuroimaging findings in newborns with congenital heart disease prior to surgery: an observational study. Arch. Dis. Child. 104, 1042–1048 (2019).
pubmed: 31243012 doi: 10.1136/archdischild-2018-314822
Glauser, T. A., Rorke, L. B., Weinberg, P. M. & Clancy, R. R. Congenital brain anomalies associated with the hypoplastic left heart syndrome. Pediatrics 85, 984–990 (1990).
pubmed: 2339047 doi: 10.1542/peds.85.6.984
Peyvandi, S. et al. Neonatal brain injury and timing of neurodevelopmental assessment in patients with congenital heart disease. J. Am. Coll. Cardiol. 71, 1986–1996 (2018).
pubmed: 29724352 pmcid: 5940013 doi: 10.1016/j.jacc.2018.02.068
Peyvandi, S. et al. Fetal brain growth and risk of postnatal white matter injury in critical congenital heart disease. J. Thorac. Cardiovasc. Surg. 162, 1007.e1–1014.e1 (2021).
Licht, D. J. et al. Brain maturation is delayed in infants with complex congenital heart defects. J. Thorac. Cardiovasc. Surg. 137, 529–536 (2009); discussion 536–527.
pubmed: 19258059 pmcid: 2701902 doi: 10.1016/j.jtcvs.2008.10.025
Peyvandi, S., Latal, B., Miller, S. P. & McQuillen, P. S. The neonatal brain in critical congenital heart disease: insights and future directions. Neuroimage 185, 776–782 (2019).
pubmed: 29787864 doi: 10.1016/j.neuroimage.2018.05.045
Naim, M. Y. et al. Subclinical seizures identified by postoperative electroencephalographic monitoring are common after neonatal cardiac surgery. J. Thorac. Cardiovasc. Surg. 150, 169–178 (2015); discussion 178–180.
pubmed: 25957454 pmcid: 4936910 doi: 10.1016/j.jtcvs.2015.03.045

Auteurs

Rachel L Leon (RL)

Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA. Rachel.Leon@UTSouthwestern.edu.

Philip T Levy (PT)

Boston Children's Hospital, Harvard Medical School, Harvard University, Boston, MA, USA.

June Hu (J)

Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Sushmita G Yallpragada (SG)

Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Shannon E G Hamrick (SEG)

Department of Pediatrics, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA.

Molly K Ball (MK)

Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH